Pharmacy Plus, Inc. dba Vital Care Compounder: Drug Recall

Recall #D-0048-2023 · 10/07/2022

Class II: Risk

Recall Details

Recall Number: D-0048-2023
Classification: Class II
Product Type: Drug
Recalling Firm: Pharmacy Plus, Inc. dba Vital Care Compounder
Status: Ongoing
Date Initiated: 10/07/2022
Location: Hattiesburg, MS, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 5 vials

Reason for Recall

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Product Description

PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150/5/50MCG / VIAL SOLUTION, 10 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

Distribution Pattern

AL, LA, MS, and TN

Other Recalls by Pharmacy Plus, Inc. dba Vital Care Compounder

Class II: Risk 04/13/2023

Lack of assurance of sterility.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

View all recalls by Pharmacy Plus, Inc. dba Vital Care Compounder →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.